Arkolith/Insider Trading/TSBX/Form 4

Orbimed Advisors LLC

Director, 10% OwnerTurnstone Biologics Corp. (TSBX) · full profile →Form 4 · filed Jul 24, 2023
Net Buying
Open-Market Buys
$5.0M
Open-Market Sells
$0
Net Open-Market Flow
$5.0M
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 20, 2023Conversion(C)2.7M——2.7M
Jul 20, 2023Buy(P)417K$12.00$5.0M3.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 20, 2023Conversion(C)937K——0
Jul 20, 2023Conversion(C)266K——0
Jul 20, 2023Conversion(C)229K——0
Jul 20, 2023Conversion(C)1.2M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000947871-23-000777) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML